Characterization of HER2 Expression Levels, Including HER2-Ultralow, in a Retrospective Male Breast Cancer Cohort
This cohort/real-world study was triaged for T9 - Rare Diseases based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.
This cohort/real-world study was triaged for T9 - Rare Diseases based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with moderate evidence maturity.
What the study was
- Study design
- Cohort/real-world study
- Sample size
- 54
- Maturity
- Validated
- Journal
- Life (Basel, Switzerland)
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.